Journal article
Mutations in MAP3K7 that alter the activity of the TAK1 signaling complex cause frontometaphyseal dysplasia
- Abstract:
- Frontometaphyseal dysplasia (FMD) is a progressive sclerosing skeletal dysplasia affecting the long bones and skull. The cause of FMD in some individuals is gain-of-function mutations in FLNA, although how these mutations result in a hyperostotic phenotype remains unknown. Approximately one half of individuals with FMD have no identified mutation in FLNA and are phenotypically very similar to individuals with FLNA mutations, except for an increased tendency to form keloid scars. Using whole-exome sequencing and targeted Sanger sequencing in 19 FMD-affected individuals with no identifiable FLNA mutation, we identified mutations in two genes-MAP3K7, encoding transforming growth factor β (TGF-β)-activated kinase (TAK1), and TAB2, encoding TAK1-associated binding protein 2 (TAB2). Four mutations were found in MAP3K7, including one highly recurrent (n = 15) de novo mutation (c.1454C>T [ p.Pro485Leu]) proximal to the coiled-coil domain of TAK1 and three missense mutations affecting the kinase domain (c.208G>C [p.Glu70Gln], c.299T>A [p.Val100Glu], and c.502G>C [p.Gly168Arg]). Notably, the subjects with the latter three mutations had a milder FMD phenotype. An additional de novo mutation was found in TAB2 (c.1705G>A, p.Glu569Lys). The recurrent mutation does not destabilize TAK1, or impair its ability to homodimerize or bind TAB2, but it does increase TAK1 autophosphorylation and alter the activity of more than one signaling pathway regulated by the TAK1 kinase complex. These findings show that dysregulation of the TAK1 complex produces a close phenocopy of FMD caused by FLNA mutations. Furthermore, they suggest that the pathogenesis of some of the filaminopathies caused by FLNA mutations might be mediated by misregulation of signaling coordinated through the TAK1 signaling complex.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 820.0KB, Terms of use)
-
(Preview, Accepted manuscript, pdf, 855.7KB, Terms of use)
-
(Preview, Accepted manuscript, pdf, 317.3KB, Terms of use)
-
- Publisher copy:
- 10.1016/j.ajhg.2016.05.024
Authors
- Publisher:
- Cell Press
- Journal:
- American Journal of Human Genetics More from this journal
- Volume:
- 99
- Issue:
- 2
- Pages:
- 392-406
- Publication date:
- 2016-08-01
- Acceptance date:
- 2016-05-22
- DOI:
- EISSN:
-
1537-6605
- ISSN:
-
0002-9297
- Pmid:
-
27426733
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:636473
- UUID:
-
uuid:a92459dd-b820-49bc-8223-422783e01cea
- Local pid:
-
pubs:636473
- Deposit date:
-
2016-09-22
- ARK identifier:
Terms of use
- Copyright holder:
- American Society of Human Genetics
- Copyright date:
- 2016
- Notes:
- Copyright © 2016 American Society of Human Genetics. This is the author accepted manuscript following peer review version of the article. The final version is available online from Cell Press at: 10.1016/j.ajhg.2016.05.024
If you are the owner of this record, you can report an update to it here: Report update to this record